Ga-67 citrate imaging in tumors of the genito-urinary tract

report of cooperative study

B. J L Sauerbrunn, G. A. Andrews, Karl Hubner

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Whole-body imaging with Ga-67 citrate in 127 tumors of the genito-urinary tract has been evaluated by a cooperative group using a uniform protocol. Primary sites of tumor were not detectable by imaging, except for one bladder and one kidney tumor. Proven and apparent metastases yielded positive scans, however, in 51% of prostatic, 50% of bladder, 72% of kidney, and 53% of testicular neoplasms. In bladder and kidney metastases, if bone sites are excluded, detection of soft tissue metastases was 61% and 75%, respectively. In embryonal-cell carcinoma of the testicle, 74% of metastatic foci were detected.

Original languageEnglish (US)
Pages (from-to)470-475
Number of pages6
JournalJournal of Nuclear Medicine
Volume19
Issue number5
StatePublished - Jan 1 1978
Externally publishedYes

Fingerprint

Urinary Tract
Urinary Bladder
Neoplasm Metastasis
Kidney
Embryonal Carcinoma Stem Cells
Whole Body Imaging
Neoplasms
Testicular Neoplasms
Testis
Bone and Bones
gallium citrate

All Science Journal Classification (ASJC) codes

  • Radiological and Ultrasound Technology

Cite this

Ga-67 citrate imaging in tumors of the genito-urinary tract : report of cooperative study. / Sauerbrunn, B. J L; Andrews, G. A.; Hubner, Karl.

In: Journal of Nuclear Medicine, Vol. 19, No. 5, 01.01.1978, p. 470-475.

Research output: Contribution to journalArticle

@article{09f73c5804184cac9f7ea271cec13c1c,
title = "Ga-67 citrate imaging in tumors of the genito-urinary tract: report of cooperative study",
abstract = "Whole-body imaging with Ga-67 citrate in 127 tumors of the genito-urinary tract has been evaluated by a cooperative group using a uniform protocol. Primary sites of tumor were not detectable by imaging, except for one bladder and one kidney tumor. Proven and apparent metastases yielded positive scans, however, in 51{\%} of prostatic, 50{\%} of bladder, 72{\%} of kidney, and 53{\%} of testicular neoplasms. In bladder and kidney metastases, if bone sites are excluded, detection of soft tissue metastases was 61{\%} and 75{\%}, respectively. In embryonal-cell carcinoma of the testicle, 74{\%} of metastatic foci were detected.",
author = "Sauerbrunn, {B. J L} and Andrews, {G. A.} and Karl Hubner",
year = "1978",
month = "1",
day = "1",
language = "English (US)",
volume = "19",
pages = "470--475",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "5",

}

TY - JOUR

T1 - Ga-67 citrate imaging in tumors of the genito-urinary tract

T2 - report of cooperative study

AU - Sauerbrunn, B. J L

AU - Andrews, G. A.

AU - Hubner, Karl

PY - 1978/1/1

Y1 - 1978/1/1

N2 - Whole-body imaging with Ga-67 citrate in 127 tumors of the genito-urinary tract has been evaluated by a cooperative group using a uniform protocol. Primary sites of tumor were not detectable by imaging, except for one bladder and one kidney tumor. Proven and apparent metastases yielded positive scans, however, in 51% of prostatic, 50% of bladder, 72% of kidney, and 53% of testicular neoplasms. In bladder and kidney metastases, if bone sites are excluded, detection of soft tissue metastases was 61% and 75%, respectively. In embryonal-cell carcinoma of the testicle, 74% of metastatic foci were detected.

AB - Whole-body imaging with Ga-67 citrate in 127 tumors of the genito-urinary tract has been evaluated by a cooperative group using a uniform protocol. Primary sites of tumor were not detectable by imaging, except for one bladder and one kidney tumor. Proven and apparent metastases yielded positive scans, however, in 51% of prostatic, 50% of bladder, 72% of kidney, and 53% of testicular neoplasms. In bladder and kidney metastases, if bone sites are excluded, detection of soft tissue metastases was 61% and 75%, respectively. In embryonal-cell carcinoma of the testicle, 74% of metastatic foci were detected.

UR - http://www.scopus.com/inward/record.url?scp=0017840127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017840127&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 470

EP - 475

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 5

ER -